James D. Brooks, MD is the Keith and Jan Hurlbut Professor in the Department of Urology at Stanford University.  He also serves as the Associate Dean of Academic Affairs in the Stanford University School of Medicine, Vice-Chair and Chief of Urologic Oncology in the Department of Urology. For more than 20 years, His group has used genomic, proteomic, metabolomic platforms and next generation sequencing to understand cancer biology and identify candidate disease biomarkers. Much of his work has focused on prostate cancer, but he also has significant research efforts in kidney, testis and bladder malignancies, as well as benign urological conditions. He has participated in several cancer research consortia including The Cancer Genome Atlas (TCGA), the Early Detection Research Network (EDRN) where he was Associate Chair of the Prostate Cancer Working Group, and the Molecular and Cellular Characterization Center Consortium for which he served as Co-Chair. Dr. Brooks has served on national advisory panels, held leadership positions in a number of research consortia, leads several NIH and Department of Defense funded research projects and serves on the editorial board of several journals.  He has participated in many clinical trials, most recently including the Canary Prostate Active Surveillance Study (PASS), the Canary Tissue Microarray resource and the EDRN Upgrading Study.  He is a urologic surgeon whose clinical practice focuses primarily on the diagnosis and treatment of prostate cancer.